Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03995225 · ClinicalTrials.gov registry record · NA
Smartband Mindfulness Study
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 155
- Enrollment target
NCT03995225: Completed NA study, sponsored by Yale University.
NCT03995225 is a NA study that has completed, run by Yale University. The registered enrollment target is 155 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03995225, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 155 participants
- Enrollment target
Study Summary
To determine treatment fidelity for a smartband/smartphone-based smoking monitoring, notification and brief mindfulness intervention.
Primary Outcome
Percent of smoking episodes detected and the rate of false alarms in the first 60 days of the study during which smokers are wearing the smartband to monitor, detect and notify them of smoking episodes.
Interventions
- BEHAVIORAL Smartband automatic smoking detection combined with brief mindfulness interventions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2020-11-22 |
| Est. Completion | 2022-03-03 |
| Phase | NA |
What the finished NCT03995225 record still lists
NCT03995225 is an interventional study that assigns participants to a tested intervention. The registered 155 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 1 intervention - of which Smartband automatic smoking detection combined with brief mindfulness interventions is the first listed.
NCT03995225 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03995225 about?
NCT03995225 is a clinical study titled "Smartband Mindfulness Study". To determine treatment fidelity for a smartband/smartphone-based smoking monitoring, notification and brief mindfulness intervention.
What is the current status of trial NCT03995225?
This trial is currently completed. It is a NA study. The enrollment target is 155 participants. The study started on 2020-11-22. Estimated completion is 2022-03-03.
What interventions are being tested in trial NCT03995225?
The interventions under investigation include: Smartband automatic smoking detection combined with brief mindfulness interventions (BEHAVIORAL).
Who is sponsoring clinical trial NCT03995225?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03995225's enrollment target sits among peer trials
155 656th of 2000 higher than 1,345 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03223610 · 155 participants · Phase 1
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
- NCT05072483 · 155 participants
Natural History Study of CADASIL
- NCT05086497 · 155 participants · NA
WBSI Guided Personalized Delivery of TTFields
- NCT05412069 · 155 participants · NA
Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI